In a statement Wednesday, Abbott said it stopped production of its Elecare specialty formula to assess storm damage and clean and re-sanitize the plant.

Formula production there restarted less than two weeks ago after a months-long closure that helped drive a nationwide formula shortage. As for the most recent closure, the company will do comprehensive testing with an independent third party before reopening.

Production and distribution of new product will likely be delayed for a few weeks. Elecare production will start first, followed by specialty and metabolic formulas.